Joanne L. Pinder

Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents

Jean‐Damien Charrier, Steven J. Durrant, Julian M.C. Golec et al. · Journal of Medicinal Chemistry · 2011 · 259 citations · Full text

Life Sciences, Medicinal Chemistry, Oncology +15

The discovery of the potent aurora inhibitor MK-0457 (VX-680)

David Bebbington, Hayley Binch, Jean‐Damien Charrier et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 99 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Rational Design of 5-(4-(Isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine (VX-970, M6620): Optimization of Intra- and Intermolecular Polar Interactions of a New Ataxia Telangiectasia Mutated and Rad3-Related (ATR) Kinase Inhibitor

Ronald M. A. Knegtel, Jean‐Damien Charrier, Steven J. Durrant et al. · Journal of Medicinal Chemistry · 2019 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +16

Preliminary feasibility studies on total synthesis of the unusual marine bryozoan alkaloids chartellamide A and B

Joanne L. Pinder, Steven M. Weinreb · Tetrahedron Letters · 2003 · 44 citations

Natural Sciences, Botany, Chemistry +15

Synthesis of the 2,3,4-trisubstituted indole fragments of nosiheptide and glycothiohexide

David J. Bentley, John Fairhurst, P. T. Gallagher et al. · Organic & Biomolecular Chemistry · 2004 · 28 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9